Androgenetic Alopecia: An Update of Treatment Options

被引：142

作者：

Kelly, Yanna ^{[1
,2
,5
]}

Blanco, Aline ^{[3
]}

Tosti, Antonella ^{[4
]}

机构：

[1] Univ Sao Paulo, Dept Dermatol, Sao Paulo, SP, Brazil

[2] Hosp Servidor Publ Municipal Sao Paulo, Dept Dermatol, Sao Paulo, SP, Brazil

[3] Univ Fed Mato Grosso do Sul, Dept Dermatol, Campo Grande, MS, Brazil

[4] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA

[5] 1364 Oscar Freire St, BR-05409010 Sao Paulo, SP, Brazil

来源：

DRUGS | 2016年 / 76卷 / 14期

关键词：

PATTERN HAIR LOSS; PLATELET-RICH PLASMA; FINASTERIDE; MG; 0.25-PERCENT TOPICAL SOLUTION; PROSTATE-SPECIFIC ANTIGEN; DOUBLE-BLIND; STEM-CELLS; 5-ALPHA-REDUCTASE INHIBITORS; AFFECT SPERMATOGENESIS; FOLLICLE REGENERATION;

D O I：

10.1007/s40265-016-0629-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Androgenetic alopecia (AGA) is characterized by a non-scarring progressive miniaturization of the hair follicle in predisposed men and women with a pattern distribution. Although AGA is a very prevalent condition, approved therapeutic options are limited. This article discusses the current treatment alternatives including their efficacy, safety profile, and quality of evidence. Finasteride and minoxidil for male androgenetic alopecia and minoxidil for female androgenetic alopecia still are the therapeutic options with the highest level evidence. The role of antiandrogens for female patients, the importance of adjuvant therapies, as well as new drugs and procedures are also addressed.

引用

页码：1349 / 1364

页数：16

共 50 条

[41] SPIRONOLACTONE (VEROSPIRON) IN THE TREATMENT OF ANDROGENETIC ALOPECIA OF WOMEN
BALOGH, E
DEBRECZENI, M
SZABOLCSY, M
[J]. BORGYOGYASZATI ES VENEROLOGIAI SZEMLE, 1985, 61 (05): : 219 - 221
[42] Androgenetic alopecia
Hoffmann, R
[J]. HAUTARZT, 2004, 55 (01): : 89 - 109
[43] Androgenetic alopecia
Lotti, TM
Menchini, G
[J]. IV INTERNATIONAL CONGRESS ON THERAPY IN ANDROLOGY: THE HUMAN TESTIS: ITS ROLE IN REPRODUCTION AND SEXUALITY, 1999, : 99 - 107
[44] Androgenetic alopecia
Tosti, A
Piraccini, BM
[J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 : 1 - 7
[45] ANDROGENETIC ALOPECIA
LUDWIG, E
[J]. ARCHIVES OF DERMATOLOGY, 1977, 113 (01) : 109 - 109
[46] Mesotherapy with dutasteride and minoxidil in treatment of androgenetic alopecia
Merino de Paz, Nayra
Vazquez-Rodriguez, Cristina
Ramirez-Fernandez, Guillermo
Garcia-Peris, Estela
Arteaga-Henriquez, Maria
Lukoviek, Vania
Rodriguez-Martin, Marina
Saez Rodriguez, Miguel
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB190 - AB190
[47] ANDROGENETIC ALOPECIA - TREATMENT RESULTS WITH TOPICAL MINOXIDIL
ROBERTS, JL
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 16 (03) : 705 - 710
[48] Treatment of androgenetic alopecia with a 7.5% herbal preparation
Greenberg, JH
Katz, M
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 1996, 7 (03) : 159 - 162
[49] New Target for Minoxidil in the Treatment of Androgenetic Alopecia
Shen, Yuqing
Zhu, Yuqi
Zhang, Li
Sun, Jiayi
Xie, Bo
Zhang, Hongyan
Song, Xiuzu
[J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 2537 - 2547
[50] OVULATION INHIBITORS FOR TREATMENT OF ANDROGENETIC ALOPECIA IN FEMALE
ZAUN, H
[J]. HAUTARZT, 1971, 22 (12): : 549 - &

← 1 2 3 4 5 →